HK Stock MarketDetailed Quotes

FUSEN PHARM (01652)

Watchlist
  • 1.080
  • 0.0000.00%
Market Closed May 29 14:23 CST
798.45MMarket Cap-60.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

FUSEN PHARM (01652) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
销售产品-双黄连口服液149.79M54.80%
销售产品-双黄连注射液48.14M17.61%
销售产品-其他药品23.71M8.67%
销售产品-清热解毒口服液14.79M5.41%
销售产品-盐酸氮柱利嗪胶囊13.3M4.86%
销售产品-三黄片12.88M4.71%
销售产品-复方硫酸亚铁颗粒10.77M3.94%
View all

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
销售产品-双黄连口服液149.79M54.80%
销售产品-双黄连注射液48.14M17.61%
销售产品-其他药品23.71M8.67%
销售产品-清热解毒口服液14.79M5.41%
销售产品-盐酸氮柱利嗪胶囊13.3M4.86%
销售产品-三黄片12.88M4.71%
销售产品-复方硫酸亚铁颗粒10.77M3.94%
View all

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
China273.37M100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 -6.41%
Sample Name
Sample Code
 -8.09%
Sample Name
Sample Code
 -9.10%
4
CNOOC
00883
-10.14%
5
SHANGHAI PECHEM
00338
-10.32%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +19.59%
Sample Name
Sample Code
 +18.95%
Sample Name
Sample Code
 +6.49%
4
Lotus Holdings
600186
+3.15%
5
China Greatwall Technology Group
000066
-0.17%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -